PMC:7445716 / 28942-29175 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T115","span":{"begin":197,"end":200},"obj":"Body_part"}],"attributes":[{"id":"A115","pred":"fma_id","subj":"T115","obj":"http://purl.org/sig/ont/fma/fma20935"}],"text":"Manganotti et al. [33] Italy 76 M 22 days after Quadriparesis UL \u003e LL, generalized areflexia, facial weakness, transient diplopia NA NA No NA Fever, cough, dysuria, hyposmia, ageusia NA Clinical + CSF + electrophysiology 1 Pure motor"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T316","span":{"begin":62,"end":64},"obj":"Disease"}],"attributes":[{"id":"A316","pred":"mondo_id","subj":"T316","obj":"http://purl.obolibrary.org/obo/MONDO_0007886"}],"text":"Manganotti et al. [33] Italy 76 M 22 days after Quadriparesis UL \u003e LL, generalized areflexia, facial weakness, transient diplopia NA NA No NA Fever, cough, dysuria, hyposmia, ageusia NA Clinical + CSF + electrophysiology 1 Pure motor"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T174","span":{"begin":34,"end":36},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"}],"text":"Manganotti et al. [33] Italy 76 M 22 days after Quadriparesis UL \u003e LL, generalized areflexia, facial weakness, transient diplopia NA NA No NA Fever, cough, dysuria, hyposmia, ageusia NA Clinical + CSF + electrophysiology 1 Pure motor"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T118","span":{"begin":67,"end":69},"obj":"Chemical"},{"id":"T119","span":{"begin":130,"end":132},"obj":"Chemical"},{"id":"T120","span":{"begin":133,"end":135},"obj":"Chemical"},{"id":"T121","span":{"begin":139,"end":141},"obj":"Chemical"},{"id":"T122","span":{"begin":183,"end":185},"obj":"Chemical"}],"attributes":[{"id":"A118","pred":"chebi_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/CHEBI_73531"},{"id":"A119","pred":"chebi_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A120","pred":"chebi_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A121","pred":"chebi_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A122","pred":"chebi_id","subj":"T122","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"}],"text":"Manganotti et al. [33] Italy 76 M 22 days after Quadriparesis UL \u003e LL, generalized areflexia, facial weakness, transient diplopia NA NA No NA Fever, cough, dysuria, hyposmia, ageusia NA Clinical + CSF + electrophysiology 1 Pure motor"}

{"project":"LitCovid-sentences","denotations":[{"id":"T164","span":{"begin":0,"end":233},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Manganotti et al. [33] Italy 76 M 22 days after Quadriparesis UL \u003e LL, generalized areflexia, facial weakness, transient diplopia NA NA No NA Fever, cough, dysuria, hyposmia, ageusia NA Clinical + CSF + electrophysiology 1 Pure motor"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T357","span":{"begin":48,"end":61},"obj":"Phenotype"},{"id":"T358","span":{"begin":83,"end":92},"obj":"Phenotype"},{"id":"T359","span":{"begin":94,"end":109},"obj":"Phenotype"},{"id":"T360","span":{"begin":121,"end":129},"obj":"Phenotype"},{"id":"T361","span":{"begin":142,"end":147},"obj":"Phenotype"},{"id":"T362","span":{"begin":149,"end":154},"obj":"Phenotype"},{"id":"T363","span":{"begin":156,"end":163},"obj":"Phenotype"},{"id":"T364","span":{"begin":165,"end":173},"obj":"Phenotype"},{"id":"T365","span":{"begin":175,"end":182},"obj":"Phenotype"}],"attributes":[{"id":"A357","pred":"hp_id","subj":"T357","obj":"http://purl.obolibrary.org/obo/HP_0002273"},{"id":"A358","pred":"hp_id","subj":"T358","obj":"http://purl.obolibrary.org/obo/HP_0001284"},{"id":"A359","pred":"hp_id","subj":"T359","obj":"http://purl.obolibrary.org/obo/HP_0030319"},{"id":"A360","pred":"hp_id","subj":"T360","obj":"http://purl.obolibrary.org/obo/HP_0000651"},{"id":"A361","pred":"hp_id","subj":"T361","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A362","pred":"hp_id","subj":"T362","obj":"http://purl.obolibrary.org/obo/HP_0012735"},{"id":"A363","pred":"hp_id","subj":"T363","obj":"http://purl.obolibrary.org/obo/HP_0100518"},{"id":"A364","pred":"hp_id","subj":"T364","obj":"http://purl.obolibrary.org/obo/HP_0004409"},{"id":"A365","pred":"hp_id","subj":"T365","obj":"http://purl.obolibrary.org/obo/HP_0041051"}],"text":"Manganotti et al. [33] Italy 76 M 22 days after Quadriparesis UL \u003e LL, generalized areflexia, facial weakness, transient diplopia NA NA No NA Fever, cough, dysuria, hyposmia, ageusia NA Clinical + CSF + electrophysiology 1 Pure motor"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T254","span":{"begin":94,"end":100},"obj":"UBERON:0001456"}],"text":"Manganotti et al. [33] Italy 76 M 22 days after Quadriparesis UL \u003e LL, generalized areflexia, facial weakness, transient diplopia NA NA No NA Fever, cough, dysuria, hyposmia, ageusia NA Clinical + CSF + electrophysiology 1 Pure motor"}

{"project":"2_test","denotations":[{"id":"32840686-32662899-63205725","span":{"begin":18,"end":20},"obj":"32662899"}],"text":"Manganotti et al. [33] Italy 76 M 22 days after Quadriparesis UL \u003e LL, generalized areflexia, facial weakness, transient diplopia NA NA No NA Fever, cough, dysuria, hyposmia, ageusia NA Clinical + CSF + electrophysiology 1 Pure motor"}